There is a characteristic decrease in glucose metabolism in associative frontal and temporo-parietal cortices of patients suffering from Alzheimer's disease (AD), The decrease in metabolism might result from local neuronal loss or from a decrease of synaptic activity, We measured in vivo r11C]methionine accumulation into pro teins with positron emission tomography (PET) to assess cortical tissue loss in AD, Both global regional activity and compartmental analysis were used to express C tC]methionine accumulation into brain tissue. Glucose metabolism was measured with C8F]fluorodeoxyglucose and autoradiographic method. Combined studies were performed in 10 patients with probable AD, compared to age-matched healthy volunteers. There was a significant
Patients suffering from probable and definite Alz heimer' s disease (AD) show a characteristic de crease in glucose metabolism in associative tem poro-parietal and frontal cortices demonstrated in vivo by positron emission tomography (PET) (Fos ter et al., 1984; Duara et al., 1986; Herholz et aI., 1993; Salmon et aI., 1994) . The relationship be tween this metabolic dysfunction and the neuropa thology of AD remains unclear. Macroscopic atro phy in AD might affect in vivo PET measurements by the inclusion of metabolically inert cerebrospinal fluid (CSF) in the regions of interest (Herscovitch et aI., 1986; Chawluk et aI., 1987) . Comparison of PET and computed tomography (CT) scan data suggest that the metabolic defect is not merely a reflection of the imaging of less tissue (de Leon et aI., 1983; Kuhl et aI., 1985; Schlageter et aI., 1987; Smith et aI., 1992) . However, glucose hypometabolism could still be explained by atrophy in terms of regional decrease in total protein content (N ajlerahim and Bowen, 1988) or in terms of cortical neuronal loss (McGeer et aI., 1986) . Alternately, the reduction of cerebral metabolic rates of glucose may reflect a decrease of synaptic activity (De Kosky and Scheff, 1990) . Glucose hypometabolism would then corre spond more to degeneration and loss of dendritic arborization than to loss of neurons (Flood and Coleman, 1986) . Moreover, decreased synaptic ac tivity could also depend upon functional and/or an atomical deafferentation of cortical neuronal cells (Procter et aI., 1988; Hamos et aI., 1989) .
We capitalized on the idea that neuronal loss should be detectable by a determination of the local rate of perikaryal protein synthesis (Lajtha et aI., 1993) in patients undergoing combined PET studies of [llC]methionine accumulation and cerebral met abolic rate of glucose who suffer from probable AD and a wide range of dementia severity. The aim was to assess the influence of tissue loss (estimated by reduction of protein synthesis) on regional glucose utilization.
SUBJECTS AND METHOD

Subjects
We studied 10 patients (six men. four women) with dementia (American Psychiatric Association, 1987), suf fering from probable AD (McKhann et aI., 1984) . T � e � were 61.5 ± 8.4 years old and their mean score at mlnI mental state examination (MMSE) (Folstein et ai., 1975) was 15.8 ± 7.2 (range, 4-23) . Disease onset corresponded to the first memory difficulties noticed by the family, and mean dementia duration was 2.6 ± 1.3 years. CT scans were normal or showed moderate diffuse atrophy. All patients underwent both e8F]fluorodeoxyglucose (l8FDG) and L-[methyl-1IC]methionine scans. Scans were performed at 1-6-week intervals, since the 18FDG pattern was used as a further selection criterion before proceeding with the P IC]methionine study. Demented subjects were compared to 16 healthy age-matched con trols who comprised one control group of II subjects (six men and five women, 59.0 ± 9.9 years old) for 18FDG studies and one control group of nine subjects (five men , II and four women, 60.7 ± 7.4 years old) for [ C]methionine. Only five control subjects underwent both 18FDG and [l1C]methionine scans. Volunteers did not have any medical problems; their neurological examinations were normal; they did not take any medication; and all had maximal scores (30/30) for MMSE. The project was ap proved by the Ethics Committee of the University of Liege. Informed consent was obtained from all subjects.
Radiochemistry
No-carrier-added 18FDG was prepared using the nu cleophilic reaction and the method of Hamacher et al. (1986) . L-{methyl-lIC]methionine was synthesized by a reac tion between llCH3I and L-homocysteine thiolactone (Comar et al., 1976) and subsequent high-performance liquid chromatography (HPLC) purification. The radio synthesis was fully automated (Delfiore et al., 1986) , and it produced 5.55 GBq (150 mCi) L-[methyl-lIC]meth ionine, 40 min after the end of bombardment. Mean spe cific activity at the end of synthesis was 46 ± 14 GBql fLmole (1243 ± 378 mCi/fLmole). Initially, pure [l1C]me thionine did not reach 100% in the radiopharmaceutical ready for injection since some products of oxidation such as [IIC]methionine sulfoxide were found in small amounts. For the subsequent nine procedures, ascorbic acid was added at the end of the synthesis to avoid the formation of by-products. contiguous transverse slices each spaced 0.3375 cm apart in a 10.8 cm axial field of view.
Reproducible positioning was insured by maintaining the patient's head with a thermolabile plastic face mask fixed on a head holder. The lower transaxial plane of the scanner was aligned parallel to and 10 mm above the or bito-meatal line. This position was checked every 5 min through crossed laser beams. All scans were performed in the morning (mean time of injection was 11: 15 a.m.), in a quiet and darkened room with the fasting subjects keep ing their eyes closed.
Correction for absorption was performed with attenu ation measured in a transmission scan using three retract able rotating rod sources.
An 8 mCi of 18FDG was injected intravenously. Blood samples were withdrawn manually throughout the study from a radial artery catheter, for both plasma radioactiv ity and plasma glucose measurements. The autoradio graphic method was applied and a 20-min emission scan was acquired 30 min after 18FDG injection.
Mean injected dose of L-[methyl-l1C]methionine was 19.5 ± 2.8 mCi. Arterial whole blood activity was mea sured at I-s intervals through a blood counter during the first 6 min of acquisition. Blood samples were also with drawn manually at I-min intervals until 6 min had elapsed, then every 5 min until the end of the study. Blood and plasma radioactivity were measured for each syringe sample. Tomographic acquisitions started at in jection time and ended 75 min later. Scan duration pro gressively increased from 5 s to 10 min.
Scan data were reconstructed with a Hanning filter and cut-off frequency set at 0.5, giving a spatial resolution of 8.7 x 8.7 x 5.8 mm at the center of the field of view (Degueldre and Quaglia, 1992) .
Plasma analysis
Percentage of unmetabolized tracer in plasma was es timated at 10,20,30,45, and 60 min in 10 subjects (seven controls and three AD patients), according to Planas et al. (1992) . Briefly, radioactivity was measured with an auto matic sample changer Berthold BF 5300 equipped with a ring-shaped NaI(TI) crystal. Trichloroacetic acid was added to plasma to precipitate proteins. The supernatant was used for HPLC analysis after derivatization with o-phtaldialdehyde, and fractions were collected to deter mine the percentage of radioactivity due to free methio nine and labelled metabolites. Table I shows the percentage of plasma free [l1C]me thionine from the injection time to 60 min after tracer injection. Free [11C]methionine did not reach 100% in the injectate due to the fact that products of oxidation were present in small amounts in the initial products. The per centage of free [11C]methionine in samples obtained 10 min after tracer injection is not significantly different from that in the injectate (paired (-test, p = 0.3). This percentage progressively decreases in subsequent sam ples, and the coefficient of variation of the measurement increases. Table 1 also shows the percentage of plasma radioactivity corresponding to proteins and metabolites.
Data analysis of 18FDG studies
Cerebral metabolic rates of glucose were calculated us ing the operational equation derived by Phelps et al. (1979) . Values of rate constants were those of the litera ture (k 1 = 0. 102, k2 = 0. 130, k3 = 0.062, and k4 0.0068), and the lumped constant was 0.42. 
10 min 20 min 30 min 45 min 60 min Circular regions of interest 0.96 cm2) were placed on parametric images of glucose consumption, in medial oc cipital, frontal and temporo-parietal cortices on 10 con tiguous planes. Values were then lumped together into one occipital region as well as left and right frontal and temporo-parietal areas in order to simplify analysis. Ra tios of metabolic values in associative versus occipital cortices were also calculated (Messa et aI., 1994) .
Data analysis of methionine studies
Time-activity curves of [II C]methionine brain distribu tion are characterized by a rapid initial accumulation for 5-10 min, after which the activity level reaches a plateau (O'Tuama et aI., 1988) . Regions of interest defined on 18FDG scans were copied, displayed, and eventually re positioned on a summed image of [IIC]methionine scans, and time-activity curves in the different brain areas were then created from dynamic acquisitions. Three different approaches were used to analyse tracer kinetics.
Cortex to occipital ratio. The cortex/occipital ratio was derived from brain activity averaged from 15 to 65 min (plateau) and expressed in percentage of injected dose per liter. The medial occipital region was taken as a reference to comply with 18FDG analysis.
Patlak-Gjedde graphical analysis. This analysis is fre quently used in tumor studies with [IIC]methionine (Bergstrom et aI., 1987; Sato et aI., 1992) . It assumes that the tracer is trapped in an irreversible compartment, and this condition seems to occur at � 15 min after injection.
Compartmental modelling. A dynamic three compartment model was used (Bustany et aI., 1985) . and three rate constants (k 1, k2, and k3) were calculated for each area. Vascular activity in the region of interest was also included in the model. The time delay between ce rebral input function and that observed for remote blood sampling was estimated; the dispersion time constant was fixed at 12 s according to our blood counter characteris tics. The modelling procedure involved a classical weight ing function, using variance of observed data. A Raph son-Newton method was applied for the minimization step.
The two latter approaches required an input function representing the amount of free [11 C]methionine in plasma. The percentage of unmetabolized tracer in plasma was measured directly for the last 10 studies (see plasma analysis). A "mean" free labelled methionine per centage curve was then derived and applied to the first studies. High frequency (l/s) continuous measurement of blood activity during the first 6 min was important for good estimation of kl in the modelization process (see data acquisition). We then assumed that whole blood and plasma activity reached an equilibrium within a few sec onds. Ratios of whole blood over total plasma radioactiv-ity calculated 20--75 min after injection were relatively constant, since coefficients of variation varied only from 2.9 to 8.9%. Those ratios were not significantly different between AD patients (0.83 ± 0.04) and controls (0.85 ± 0.0 1, p = 0.44 using an unpaired t-test) and were used to generate a total plasma time-activity curve from early continuous recording of whole blood radioactivity. Table 2 shows regional cerebral metabolic rates of glucose in 10 patients with probable AD com pared to 11 healthy age-matched volunteers. All values of cortical metabolism are significantly lower in AD than in controls. Reduction of metabolism was more significant in the temporo-parietal cortex (45% decrease) than in frontal or occipital regions (25 and 22% decreases, respectively, compared to mean control values).
Statistics
RESULTS
Metabolic rates of glucose
In the population of AD patients, ratios of asso ciative over occipital cortical metabolic values were significantly decreased in temporo-parietal cortices only. When left and right values were averaged, there was an optimal discrimination in temporo parietal regions, where all ratios were decreased in patients compared to healthy volunteers (Fig. 1) . Cerebral metabolic rates of glucose in mg/100 g/min (mean ± SD). a Significant difference between AD and control mean values:
h Significant difference between AD and control mean values:
Averaged (right and left) values of regional over oc cipital glucose metabolic ratios in frontal and temporo parietal associative cortices for controls and patients with AD.
Most frontal metabolic ratios of AD patients were in the normal range.
[ ll C]Methionine distribution
Values of cerebral activity after [l1C]methionine distribution, expressed as a percentage of injected dose per liter, ranged from 1.9 in frontal to 2.4 in occipital regions. They were not significantly differ ent between patients and controls. Cerebellar activ ity measured in AD patients was higher than in any other region of both controls and AD; thus, we did not consider the cerebellum as a reference.
When the occipital region was used as reference
controls AD controls
to calculate ratios of [llC]methionine distribution, values were not significantly different between pa tients and controls. Fig. 2 , however, shows that all but one patient had temporo-parietal values lower than the control mean, while frontal values were similarly distributed between both groups.
[ ll C]Methionine Patlak-Gjedde analysis
Values of the unidirectional influx constant of [llC]methionine from plasma to associative cortices (K) were obtained in nine patients and seven con trols (data not shown). The plasma-free [llC]me thionine curve was not available in one patient and two controls. Mean values, expressed as min -], ranged from 1.42 (frontal) to 1.82 (occipital) in con trols and from 1.32 (frontal) to 1.69 (occipital) in patients. There was a moderate but not significant decrease of Ki in AD compared to controls, with a maximal mean reduction of 13 and 15% in right and left temporocparietal cortices, respectively. Table 3 contains the values of rate constants k 1, k2, and k3 obtained in cortical regions using the compartmental modelling approach. Values of kl and k2 are generally lower but not significantly dif ferent in patients than in controls. Similar brain plasma distribution volumes of e IC]methionine (kll k2 + k3) were obtained in the AD and control groups, with occipital values (0.34) slightly higher than values in associative cortices (mean 0.30; data not shown). Values of k3 are decreased in the tem poro-parietal cortex of AD patients (22% and 20% (10 E-2) (10 E-2) (10 E-2) in right and left regions, respectively) but the de crease is significant on the right side only. Table 3 also displays the values of e IC]methionine plasma to brain accumulation rate constant (kl x k3/k2 + k3), showing a nonsignificant decrease predomi nant in both temporo-parietal regions of the AD group. The decrease reaches 17% and 20% of con trol values in right and left regions, respectively. Rate constants of plasma to brain e IC]methio nine accumulation obtained with the three compartment model are highly correlated with those derived from Patlak-Gjedde analysis.
[ ll C]Methionine modelling
---------- ----_._--- Controls AD Controls AD Controls AD Controls AD (n = 7) (n = 9) (n = 7) (n = 9) (n = 7) (n = 9) (n = 7) (n = 9) "_._------------------.
Relationships between glucose metabolism, [ ll C]methionine distribution and severity of dementia
The severity of dementia, expressed by the MMSE score, is significantly correlated with the metabolic rates of glucose in right and left temporo parietal cortices (Spearman correlation, p = 0.02 and p = 0.005, respectively), but not in frontal re gions. There is no relationship between MMSE scores and the different values describing regional e lC]methionine distribution.
When we paired percentages of decrease for each patient (compared to respective mean control val- ues), cerebral metabolic rates of glucose were sig nificantly more reduced than were rate constants of plasma to brain [11C]methionine accumulation (paired t-test, p < 0.001). We did not observe any direct correlation between metabolic rates of glu cose and values of e IC]methionine cerebral distri bution in our AD patients. However, Fig. 3 shows a positive correlation between asymmetries of distri bution of glucose metabolism and [llC]methionine in temporo-parietal cortices, i.e., right/left ratios of cerebral metabolic rates of glucose and cerebral activity after [llC]methionine administration (Spearman correlation, p = 0.004). The correlation is negative between asymmetries of glucose metab olism and asymmetries of k2 and k3 rate constants describing e IC]methionine exchanges in temporo parietal cortices (Spearman correlation, p = 0.005 and p = 0.007, respectively).
DISCUSSION
Glucose metabolism in AD
All patients fulfill NINCDS-ADRDA work group criteria for probable AD (McKhann et ai., 1984) . Mean cerebral metabolic rates of glucose are de creased in all cortical regions and all patients show reduced glucose metabolic ratios in temporo parietal cortices (Foster et aI., 1984; Kuhl et aI., 1985; Duara et aI., 1986; Haxby et aI., 1986; Her holz et aI., 1993) . Although significantly reduced in the patient group, metabolism of individual subjects is less frequently affected in frontal than in poste rior associative cortices (Kuhl et aI., 1985) . In our population, mean disease duration is only 3 years and shows no correlation to cerebral metabolic rates of glucose. Patients have a wide range of MMSE scores, significantly correlated to temporo parietal metabolism (Haxby et aI., 1985) . Thus, ce rebral glucose consumption is a functional parame ter related to the severity of dementia in AD.
Behavior of [ l1 C]methionine in brain tissue
Tracer kinetic measurement of cerebral protein synthesis can be approached with PET (Phelps et al., 1984) . L-[llC-methyl]methionine is relatively easy to synthesize and it is frequently used as a tracer (Comar et aI., 1976; Vaalburg et aI., 1993) . A brief review of e lC]methionine behavior will help to interpret our results. L-methionine is transported through the blood-brain barrier and accumulates in neurons and glial cells. Methionyl-tRNA, the real precursor pool for protein synthesis, represents only a small fraction of the free methionine pool. However, the specific activity of both pools is the same and they can be combined in a simplified model describing amino acid incorporation into pro teins (Grange et aI., 1992) . Brain proteins comprise a large pool (mainly structural proteins) with sev eral days' half life and a small fraction (probably enzymes) with few hours' half life. Mean brain pro tein half life is �4 days (Lajtha et aI., 1976; Lajtha and Dunlop, 198 1) . There is a constant turnover; and, since the amount of the amino-acid in proteins is much larger than its free concentration, most of the labelled amino-acid will be detected in cerebral proteins in the hour following its intravenous ad ministration. L-e IC-methyl]methionine also follows transmethylation (and transsulfuration) cycle. Me thionine is transformed in S-adenosyl-methionine, a major methyl donor· for many biochemical reac tions. Labelling is then transferred to various meth yl acceptors. The relative rate of methionine flux into the transmethylation cycle is estimated at 10% of the rate of methionine incorporation into brain proteins, so that metabolism of methionine is mainly directed towards protein synthesis (Grange et aI., 1992) . Kinetic analysis is based on a three compartment model that does not take minor met abolic pathways into account (Bustany et aI., 1985; Blomqvist et aI., 1993) . Labelled amino-acid accu mulation rate into tissue proteins can then be deter-J Cereb Blood Flow Metab, Vol. 16, No. 3, 1996 mined. However, the kinetic approach assumes that the specific activity of the precursor pool is similar to that measured in plasma. In fact, the precursor pool is further diluted by amino acid originating from intracellular protein breakdown. Thus, tracer approach measures an apparent amino acid incor poration rate that depends both on the exact rate of amino acid incorporation into proteins and on dilu tion of the precursor pool by protein breakdown. The exact amino acid incorporation rate is then un derestimated since amino-acid recycling cannot be taken into account in the mathematical model. To date, methionine is the amino acid that presents the lowest degree of dilution in the precursor pool for protein synthesis (Grange et aI., 1992) . Finally, amino acid incorporation into proteins is rapid com pared to the brain proteins' average half life of sev eral days, and recycling of the labelled amino acids from protein breakdown can be neglected during the time of PET.
Plasma analysis
Our values of plasma lllC]methionine and lIIC]_ labelled proteins measured at 60 min are very close to those obtained in the plasma of patients with brain tumors (Sato et aI., 1992; lshiwata et aI., 1989) . These authors suggested that the fraction of labelled metabolites in plasma could vary consider ably between subjects. Their percentage of plasma e lC]methionine and plasma labelled proteins varied between 16 and 72% and between 13 and 74%, re spectively. Our standard deviations are quite lower (Table 1) , and "standard" averaged values seem acceptable in our groups of subjects and for our study conditions.
[ II C IMethionine distribution
Values of regional cerebral activity after [llC]me thionine administration and regional to occipital ra tios did not differ significantly between patients and controls. The main drawback of simple regional ac tivity values is their dependence upon whole body distribution of the injected dose. The drawback of all ratio methods is that the measurement IS Im paired in the reference tissue itself.
Patlak-Gjedde analysis
Our control values of accumulation rate constant obtained with Patlak-Gjedde graphical evaluation are very close to those already published (Berg strom et aI., 1987) . There is a trend for a decrease of the values in AD, but the difference between pa tients and controls do not reach significance. The main drawbacks of this analysis are the inclusion of cerebral blood volume in the rate constant and the difficulty in defining the portion of the curve to an alyze.
[ ll C]Methionine distribution modelling
Mean transfer constants of [' lC]methionine be tween plasma and cerebral precursor pool (k 1 and k2) are lower in AD than in controls, but the tracer distribution volume is similar in both groups. The rate constant for incorporation of [11C]methionine from the precursor pool into proteins (k3) is signif icantly decreased in the right temporo-parietal cor tex of AD only. This decrease, nevertheless, re flects a local reduction of protein synthesis. The rate constant for accumulation of plasma [I I C]me_ thionine into tissue (kl x k3/k2 + k3) is (nonsignif icantly) decreased in the temporo-parietal cortex more than in the frontal regions of our patients. Because we cannot estimate amino acid recycling, it is impossible to differentiate between decreased rates of labelled amino acid incorporation into pro teins and increased rates of protein degradation (with dilution of the amino-acid precursor pool). However, cytoplasmic RNA content and nuclear and nucleolar volumes are reduced in AD (Tomlin son, 1984; Neary et a!., 1986; Mann et a!., 1988) , and a decrease of protein synthesis is more likely than is an increase of protein breakdown. We will discuss this hypothesis further in the next para graph. It is not possible to specify whether the small fast fraction is more or less affected than is the large slow bulk of brain proteins (Lajtha et a!., 1981) , but a decrease of enzymatic or structural protein syn thesis corresponds, in any case, to neuronal loss and degeneration. Bustany et al. (1985) reported an important de crease in protein synthesis rate in the frontal lobes of patients with senile AD. Their mean decrease was 15% in patients with mild dementia, and reached 65% when cognitive troubles were severe. In their figures, temporo-parietal cortices appeared to be less affected. We obviously studied a different population. In our younger patients with short dis ease duration, [, IC]methionine accumulation rate constants showed a mean 15% reduction in the fron tal cortex and a mean 20% reduction in the tem poro-parietal cortex. The maximal individual de crease was 37%. Overlapping of values may come from methodological limitations. Coefficients of variation reached 14-21%, which, although not bad for PET (Friedland et aI., 1989; Jagust et aI., 1991) , might mask a physiologically significant change of [llC]methionine accumulation. Modelling [IIC]me_ thionine distribution with three compartments is clearly a simplification, but it is hardly possible to introduce more variables into the model. Finally, the relatively small size of regions of interest and correction of plasma activity for metabolites may introduce noise into data that affects estimates of kl, k2, and k3.
The main drawback is that PET measures only an apparent rate of accumulation of plasma [IIC]me_ thionine into proteins, because dilution of the amino-acid precursor pool is not taken into ac count. However, assuming a plasma concentration in methionine of 20 nmol/ml (O'Tuama et aI., 1988; Clarke et aI., 1989) , we obtained apparent protein synthesis rates of 0.34 and 0.28 nM/min/ml in the temporo-parietal cortex of controls and AD, respec tively. These values are in agreement with those reported in the literature (Bustany et aI., 1985; Lestage et aI., 1987) .
Comparison of glucose metabolism and protein synthesis
A possible methodological problem when we compare measurements of glucose metabolism and protein synthesis in our patients is that we used two different control groups and two different methods of analysis-autoradiographic 18FDG studies ver sus kinetic analysis of labelled methionine distribu tion. The autoradiographic method also tends to un derestimate glucose utilization in hypometabolic ar eas. However, comparison of our five controls with combined 18FDG and [IIC]methionine studies to AD patients did not modify our results. On the other hand, previous studies with 18FDG showed a highly significant correlation between cerebral met abolic rates of glucose obtained with kinetic analy sis and autoradiography in AD and controls (Fuku yama et aI., 1989) , and values calculated from dy namic acquisitions were significantly decreased in associative cortices of patients (Fukuyama et aI., 1989; Jagust et a!., 1991; Antonini et aI., 1995) . We can then rely on the very significant difference we obtained in our patients between paired percentage of decrease in glucose utilization, on the one hand, and in rate constants for lllC]methionine accumu lation, on the other.
In contrast to glucose metabolism in the temporo parietal cortex, our indices of [' lC]methionine brain accumulation did not correlate with severity of de mentia. There was a single positive correlation in the temporo-parietal cortex between asymmetries of glucose metabolism, on the one hand, and those of cerebral activity after [IlC]methionine adminis tration, on the other, pointing to a very crude rela tionship between metabolic rates of glucose and rates of protein synthesis in those regions. How ever, there was also a negative correlation in the same regions between asymmetries of glucose con-sumption and those of k2 and k3 values. Higher apparent k2 and k3 values in areas with lower glu cose metabolism might correspond to a lesser dilu tion of the precursor pool due to decreased protein breakdown. In other words, higher apparent rate constants in tracer kinetic analysis correspond, in fact, to a higher specific activity in the precursor pool, where free endogenous amino acid concentra tion is lowered. A simplified explanation for this negative correlation might be that there is an impor tant decrease of functional activity in the temporo parietal cortices and, to a lesser degree, a reduction of the number of neurons (with lower rates of global protein synthesis), while neurofibrillary tangles, as well as senile plaques, sequester structural pro teins.
Conclusion
Our AD patients had a significant (45%) decrease of mean temporo-parietal glucose metabolism com pared to that of healthy age-matched controls. Cor tical accumulation rates of [II C]methionine were lower in AD than in controls, with a mean decrease of 20% in temporo-parietal regions; however, the majority of measurements were not significantly de creased.
We avoided the problem of regional macroscopic atrophy (Chawluk et al., 1987) . Our data were ob tained in the same population and with the same PET technique; partial volume effect should affect both 18FDG and L llC]methionine measurements similarly, because of similar spatial distribution. PET studies with [IIC]methionine only provide an apparent protein synthesis rate. Dilution of the amino-acid precursor pool cannot be taken into ac count in the model. However, our data suggest that dilution of the precursor pool becomes less impor tant in AD, because protein breakdown might be decreased.
We discussed methodological drawbacks in e lC]methionine analysis that could hamper the de tection of significant decreases in most of our mea surements of protein synthesis in AD. Alternately, neuropathological studies demonstrated a 27-52% decline in the ratio of neurons to glia in AD (Hansen et aI., 1988) . A relative increase of glial cells in as sociative cortices could mask the modifications in neuronal biochemical measurements. This was not the case, however, for 18FDG studies (McGeer et aI., 1986) . Neither is there evidence in the literature that protein synthesis of the glial population is in creased in AD or might counterbalance the de crease of mean amino-acid accumulation related to neuronal loss. The differential incorporation of amino-acids into neurons or glia is a matter J Cereh Blood Flow Metah, Vol. 16, No.3, 1996 of discussion, but neurons seem to synthesize pro teins at a higher rate than do glial cells (Hamberger et aI., 1971; Hamberger and Sourander, 1978; Re isert et aI., 1979; Shahbazian et al., 1986) . Although there is a prominent increase in fibrous astrocytes in AD, they can derive by transformation from pro toplasmic astrocytes (Schechter et al., 1981) . Effec tively, modification of the entire population of glial cells is highly variable in AD. While there is a sig nificant 26-36% decrease in all neurons, glial cells are either decreased (12%) in the superior temporal cortex or non significantly increased (54%) in the inferior parietal cortex (Hansen et aI., 1988) . Fi nally, when specific changes of mRNA pool size are studied, there is a global decrease of 18S ribosomal RN A in AD. There is no significant change of glial fibrillary acid protein or neurofilament associated tau protein mRNA pool sizes in the neocortex of AD compared to controls, while the concentration of some neuron-specific mRNA shows the greatest reduction (Lukiw et aI., 1991) .
Thus, admitting that the decrease of cortical ac cumulation rates of e lC]methionine reflects mainly neuronal loss and reduction of cytoplasmic RNA content (Lajtha, 1993; Mann et aI., 1988; Neary et aI., 1986) , our in vivo data show that tissue loss is not sufficient to explain the cortical glucose hypo metabolism in AD. Neuronal protein synthesis is restricted to the perikarion, and peripheral trans port can hardly be important for the PET study time (Hammerschlag and Brady, 1989) . Markers of neu ronal membranes are preferentially decreased in AD in comparison to decreases in DNA and RNA levels (DeKosky and Bass, 1982) . Neurohistochem ical studies of glucose transport and pyruvate dehy drogenase in rat suggest that anaerobic glucose deg radation occurs mostly in neuropil (dendrites and axons), while aerobic oxygen metabolism is local ized to neuronal perikaria (Bagley et al., 1989; Dick and Harik, 1986) . Our data, together with these ob servations, favor the hypothesis that decrease of synaptic connectivity (Flood and Coleman, 1986; Davies et aI., 1987) is more important than neuronal loss in accounting for reduction of cortical glucose utilization.
